| human | Q5 |
| P106 | occupation | researcher | Q1650915 |
| Q45933381 | 5-HTR1A, 5-HTR2A, 5-HTR6, TPH1 and TPH2 polymorphisms and major depression. |
| Q92451898 | A catalog of genetic loci associated with kidney function from analyses of a million individuals |
| Q39024723 | A genome-wide expression quantitative trait loci analysis of proprotein convertase subtilisin/kexin enzymes identifies a novel regulatory gene variant for FURIN expression and blood pressure |
| Q40424364 | Activated immune-inflammatory pathways are associated with long-standing depressive symptoms: Evidence from gene-set enrichment analyses in the Young Finns Study |
| Q46809019 | Adult-type hypolactasia is not a predisposing factor for the early functional and structural changes of atherosclerosis: the Cardiovascular Risk in Young Finns Study |
| Q57274812 | Androgen receptor CAG polymorphism and prostate cancer risk |
| Q36694184 | Associations of functional alanine-glyoxylate aminotransferase 2 gene variants with atrial fibrillation and ischemic stroke |
| Q47661605 | BDNF and NRG1 polymorphisms and temperament in selective serotonin reuptake inhibitor-treated patients with major depression |
| Q48109119 | BDNF polymorphism rs11030101 is associated with the efficacy of electroconvulsive therapy in treatment-resistant depression |
| Q38727721 | Blood pathway analyses reveal differences between prediabetic subjects with or without dyslipidaemia. The Cardiovascular Risk in Young Finns Study |
| Q35098697 | CYP1A2 polymorphism -1545C > T (rs2470890) is associated with increased side effects to clozapine |
| Q43195469 | Catechol-O-methyltransferase val108/158met genotype, major depressive disorder and response to selective serotonin reuptake inhibitors in major depressive disorder |
| Q37609680 | Differentially expressed genes and canonical pathway expression in human atherosclerotic plaques - Tampere Vascular Study |
| Q41772435 | Differentially expressed genes and canonical pathways in the ascending thoracic aortic aneurysm - The Tampere Vascular Study |
| Q46311163 | Dopamine 2 receptor C957T and catechol-o-methyltransferase Val158Met polymorphisms are associated with treatment response in electroconvulsive therapy |
| Q42342101 | Erratum: Genetic loci associated with heart rate variability and their effects on cardiac disease risk |
| Q30276497 | Exome Genotyping Identifies Pleiotropic Variants Associated with Red Blood Cell Traits |
| Q57258998 | ExomeChip-Wide Analysis of 95 626 Individuals Identifies 10 Novel Loci Associated With QT and JT Intervals |
| Q88277546 | Genetic Polymorphisms Associated With Constipation and Anticholinergic Symptoms in Patients Receiving Clozapine |
| Q28654771 | Genetic association study of QT interval highlights role for calcium signaling pathways in myocardial repolarization |
| Q30313100 | Genetic loci associated with heart rate variability and their effects on cardiac disease risk |
| Q34147477 | Genetic profiling using genome-wide significant coronary artery disease risk variants does not improve the prediction of subclinical atherosclerosis: the Cardiovascular Risk in Young Finns Study, the Bogalusa Heart Study and the Health 2000 Survey-- |
| Q33717049 | Genetic variants and their interactions in the prediction of increased pre-clinical carotid atherosclerosis: the cardiovascular risk in young Finns study |
| Q34534157 | Genetic variation in the hTAS2R38 taste receptor and food consumption among Finnish adults |
| Q79289953 | Germ-line alterations in MSR1 gene and prostate cancer risk |
| Q35764687 | Germline alterations of the RNASEL gene, a candidate HPC1 gene at 1q25, in patients and families with prostate cancer |
| Q47396785 | Histaminergic gene polymorphisms associated with sedation in clozapine-treated patients |
| Q47255631 | INSIG2 polymorphism and weight gain, dyslipidemia and serum adiponectin in Finnish patients with schizophrenia treated with clozapine |
| Q48829855 | Interaction between two HTR2A polymorphisms and gender is associated with treatment response in MDD. |
| Q49122438 | Is 5-HTTLPR linked to the response of selective serotonin reuptake inhibitors in MDD? |
| Q39602792 | Melatonin pathway genes are associated with progressive subtypes and disability status in multiple sclerosis among Finnish patients |
| Q60526169 | Mitochondrial diabetes is associated with insulin resistance in subcutaneous adipose tissue but not with increased liver fat content |
| Q47886629 | Motherhood and oxytocin receptor genetic variation are associated with selective changes in electrocortical responses to infant facial expressions. |
| Q95322411 | Multi-ancestry GWAS of the electrocardiographic PR interval identifies 202 loci underlying cardiac conduction |
| Q34253730 | No association of nineteen COX-2 gene variants to preclinical markers of atherosclerosis The Cardiovascular Risk in Young Finns Study |
| Q48249396 | No support for a role for BDNF gene polymorphisms rs11030101 and rs61888800 in major depressive disorder or antidepressant response in patients of Finnish origin |
| Q37642929 | Obesity accelerates epigenetic aging in middle-aged but not in elderly individuals |
| Q48907841 | P2RX7 polymorphisms Gln460Arg and His155Tyr are not associated with major depressive disorder or remission after SSRI or ECT. |
| Q30276496 | Platelet-Related Variants Identified by Exomechip Meta-analysis in 157,293 Individuals |
| Q87672943 | Polymorphism in alpha 2A adrenergic receptor gene is associated with sialorrhea in schizophrenia patients on clozapine treatment |
| Q43287698 | Polymorphism in the IL10 promoter region and early markers of atherosclerosis: the Cardiovascular Risk in Young Finns Study |
| Q46386747 | Polymorphism in the IL6 promoter region is associated with the risk factors and markers of subclinical atherosclerosis in men: The Cardiovascular Risk in Young Finns Study |
| Q37397317 | Polymorphisms in genes involved in androgen pathways as risk factors for prostate cancer |
| Q41019601 | Predicting sudden cardiac death using common genetic risk variants for coronary artery disease |
| Q57274798 | Profiling Genetic Variation along the Androgen Biosynthesis and Metabolism Pathways Implicates Several Single Nucleotide Polymorphisms and Their Combinations as Prostate Cancer Risk Factors |
| Q46963792 | Regulatory variant of the TPH2 gene and early life stress are associated with heightened attention to social signals of fear in infants |
| Q48102826 | SERT and NET polymorphisms, temperament and antidepressant response |
| Q48122222 | Serotonin transporter (5-HTTLPR) and norepinephrine transporter (NET) gene polymorphisms: susceptibility and treatment response of electroconvulsive therapy in treatment resistant depression |
| Q43252463 | TPH1 218A/C polymorphism is associated with major depressive disorder and its treatment response |
| Q34676880 | TPH1 A218C polymorphism and temperament in major depression |
| Q90442174 | Target genes, variants, tissues and transcriptional pathways influencing human serum urate levels |
| Q42785023 | Temperament profiles, 5-HT2A genotype, and response to treatment with SSRIs in major depression |
| Q44445750 | The APOE -219G/T and +113G/C polymorphisms affect insulin resistance among Turks |
| Q92458814 | The SGLT2 Inhibitor Dapagliflozin Reduces Liver Fat but Does Not Affect Tissue Insulin Sensitivity: A Randomized, Double-Blind, Placebo-Controlled Study With 8-Week Treatment in Type 2 Diabetes Patients |
| Q34495057 | Trans-ancestry genome-wide association study identifies 12 genetic loci influencing blood pressure and implicates a role for DNA methylation |
| Q44230875 | Vascular cell adhesion molecule 1, soluble Fas and hepatocyte growth factor as predictors of mortality in nonagenarians: the Vitality 90+ study |
| Q43086381 | Vascular endothelial growth factor (VEGF) polymorphism is associated with treatment resistant depression |
Search more.